Impact Factor
3.83
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.33
3,683 total citations
h5-index
42
h5 depth signal
Cited share
75.9%
859 of 1,132
Total citations
3,683
Citation footprint
Metric signal
3.22
External metric anchor
Self-citation
11.1%
409 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,035
China
965
Germany
753
Italy
725
France
647
Citing Fields of Research
Urology
2,635
Kidney Diseases
1,646
Prostate Cancer
1,207
Oncology
221
Abdominal Surgery
209
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,236
Articles tracked across the journal lifetime
Indexed publication set
1,132
859 cited publications
Last 12 months
852
71.0 publications/month
Open access share
25.6%
218 OA publications in the last year
Leading citing country
United States
1,035 citing publications
Leading citing field
Urology
2,635 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v11n1, 1993-
v11n1, 1993-
Active Coverage
Research Focus & Classification
Indexed Subjects
Urology
Kidney Diseases
Issuing & Sponsoring Bodies
Contributor
Urological Research Society
Broad Categories
Urology
Kidney Diseases
Prostate Cancer
MeSH Descriptors
Urology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s00345-026-06865-5
Open DOI
Calcium oxalate kidney stone morphology reflects underlying metabolic and clinical conditions
02
03
DOI 10.1007/s00345-026-06849-5
Open DOI
Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics
Purpose: To investigate cancer-control outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients receiving Lutetium-177 Prostate-Specific Membrane Antigen-617 (Lu-177-PSMA) radioligand therapy according to initial base...
04
05
DOI 10.1007/s00345-026-06874-4
Open DOI
Mini-PCNL and mini-ECIRS in a solitary kidney population: a single-center experience
06
07
DOI 10.1007/s00345-026-06856-6
Open DOI
Assessment of accuracy, quality, and readability of large language models in kidney transplantation practice
08
DOI 10.1007/s00345-026-06872-6
Open DOI
Confidence without consensus? Human versus AI abstracts in urology
Objective: This study asked whether urologists can tell human-written abstracts apart from artificial intelligence (AI)-written abstracts when both describe the same study, and whether the answer depends on which AI model did the writing...
09
DOI 10.1007/s00345-026-06811-5
Open DOI
EQUIPOISE: EQUivalence In Prostate cancer treatment: surgery Or radiotherapy? An Intention-to-treat Survival analysis from real-world Evidence
Purpose: To compare cancer-specific and overall survival between a surgery-based strategy and radiotherapy plus androgen deprivation (RT + ADT) in intermediate- and high-risk localized prostate cancer, using contemporary real-world data ...
10
DOI 10.1007/s00345-026-06735-0
Open DOI
Safety and complications of upper pole puncture in supine percutaneous nephrolithotomy
Objective: Supine percutaneous nephrolithotomy (PCNL) has gained attention as a viable alternative to the traditional/historical prone approach for the treatment of large renal stones. However, concerns remain regarding the safety and fe...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
-2022: official journal of the Urological Research Society.
Vol. 1, no. 1 (APRIL 1983)19930601 Notice published Printed on acid-free paper